← 返回

口腔鳞状细胞癌中 TIL(肿瘤浸润淋巴细胞)亚群及其各自预后影响

英文原题:Tumour-infiltrating lymphocyte subsets and their individual prognostic impact in oral squamous cell carcinoma.

查看英文原题

Tumour-infiltrating lymphocyte subsets and their individual prognostic impact in oral squamous cell carcinoma.

PubMed 2024/11/19(内容时间) J Clin Pathol Q2 · IF 2.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

宿主免疫反应及其与癌细胞的相互作用对口腔鳞状细胞癌(OSCC)的结局有显著影响,其中某些 TIL 亚群比其他亚群更具临床相关性。

中文摘要

口腔鳞状细胞癌(OSCC)的预后因素尚未得到充分阐明,这可能是治疗反应和患者结局存在显著差异的原因之一。本回顾性观察研究旨在评估不同TIL(肿瘤浸润淋巴细胞)亚群对预后的影响。

采用免疫组织化学定量评估50例接受手术治疗的OSCC病例中CD3+、CD20+、CD4+、CD8+和FOXP3+ TIL亚群的细胞密度,并分析其与无病生存期(DFS)和总生存期(OS)的关系。通过受试者工作特征曲线和Youden指数确定具有预后意义的截断值。

每高倍视野中CD3+、CD4+、CD8+、CD20+和FOXP3+ TIL的平均计数分别为243、52、132、53和116个。CD8+ TIL计数较高、FOXP3+ TIL计数较低以及CD8:FOXP3比值较高,均与更长的DFS和OS及更有利的肿瘤-宿主界面特征显著相关。

宿主免疫反应及其与癌细胞的相互作用显著影响OSCC结局,不同TIL亚群的临床相关性也有所不同。CD8+细胞毒性T细胞和FOXP3+调节性T细胞(Treg)计数较低,以及较高的CD8:FOXP3比值,均与良好预后相关。这些发现可为开发通过减少FOXP3+淋巴细胞浸润或调节其信号通路来重塑肿瘤免疫微环境的新型药物提供线索。

展开英文摘要原文

Immunohistochemistry was performed to quantitatively assess cell densities of CD3+, CD20+, CD4+, CD8+ and FOXP3+TIL subsets in 50 surgically treated OSCC cases. Results were correlated with disease-free survival (DFS) and overall survival (OS). Receiver operating characteristic curve analysis and Youden index were applied to determine prognostically significant cut-off values.

Mean counts for CD3+, CD4+, CD8+, CD20+ and FOXP3+TILs were 243, 52, 132, 53 and 116 cells per high power field, respectively. High CD8+ and low FOXP3+TIL counts, and high ratio of CD8:FOXP3 were significantly associated with longer DFS and OS, as well as with improved tumour-host interface parameters.

Host immune response and its interaction with cancer cells have a significant impact on OSCC outcomes, with some TIL subsets being more clinically relevant than others. High cytotoxic T-cell (CD8) and low Treg (FOXP3) counts, and high cytotoxic T-cell to Treg (CD8:FOXP3) ratio are significantly associated with favourable prognosis. These results may serve as a leading point in identifying novel therapeutic agents that can redesign the tumour immune microenvironment by reducing infiltrating FOXP3-lymphocytes, and modifying their signalling pathways.

论文信息

作者
Kakkar A、Thakur R、Roy D、Sood R、Sharma A、Malhotra RK、Thakar A
第一作者单位
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India draanchalkakkar@aiims.edu drathakar@gmail.com.India
通讯作者单位
Department of Otorhinolaryngology & Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India draanchalkakkar@aiims.edu drathakar@gmail.com.India
文献类型
观察性研究
期刊
Journal of clinical pathology2024 Nov 19
原文标识
PubMed 37699696 · DOI 10.1136/jcp-2023-208918